Safety and Immunogenicity of Early Measles Vaccination in Children Born to HIV-Infected Mothers in the United States: Results of Pediatric AIDS Clinical Trials Group (PACTG) Protocol 225

Background. PACTG (Pediatric AIDS Clinical Trials Group) 225, a multicenter, randomized, open-label trial in the United States evaluated reactogenicity and immunogenicity of 2 vaccination regimens: monovalent measles vaccine (Attenuvax) at 6 months of age and measles, mumps, and rubella, live attenu...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Chandwani, Sulachni, Beeler, Judy, Li, Hong, Audet, Susette, Smith, Betsy, Moye, John, Nalin, David, Krasinski, Keith
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2011
Matèries:
Measles Vaccine Safety and Effectiveness
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3143449/
https://ncbi.nlm.nih.gov/pubmed/21666159
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jir089
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars